ShareValue scores for GELS: Valuation 53, Quality 51, Growth 64, Health 51.
GELSNASDAQ
Gelteq Limited Ordinary Shares
$0.54
(-2.66%)
GELSNASDAQ
Gelteq Limited Ordinary Shares
$0.54(-2.66%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
53
Fair Value
Price vs Value
Quality
51
Moderate
Business Strength
Growth
64
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
82
Bullish
Price Trend
Company Details
About
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Market Cap$6M
P/E RatioN/A
Dividend YieldNone
Sector Rank#592
Score Analysis
AI Investment Thesis
Data as of:Jul 10, 2026
|Last calculated:Jul 10, 2026